37 CFR 1.823 - Requirements for nucleotide and/or amino acid sequences as part of the application.

Status message

There are 5 Updates appearing in the Federal Register for 37 CFR 1. View below or at eCFR (GPOAccess)
§ 1.823 Requirements for nucleotide and/or amino acid sequences as part of the application.
(a)
(1) If the “Sequence Listing” required by § 1.821(c) is submitted on paper: The “Sequence Listing,” setting forth the nucleotide and/or amino acid sequence and associated information in accordance with paragraph (b) of this section, must begin on a new page and must be titled “Sequence Listing.” The pages of the “Sequence Listing” preferably should be numbered independently of the numbering of the remainder of the application. Each page of the “Sequence Listing” shall contain no more than 66 lines and each line shall contain no more than 72 characters. The sheet or sheets presenting a sequence listing may not include material other than part of the sequence listing. A fixed-width font should be used exclusively throughout the “Sequence Listing.”
(2) If the “Sequence Listing” required by § 1.821(c) is submitted on compact disc: The “Sequence Listing” must be submitted on a compact disc in compliance with § 1.52(e). The compact disc may also contain table information if the application contains table information that may be submitted on a compact disc (§ 1.52(e)(1)(iii)). The specification must contain an incorporation-by-reference of the Sequence Listing as required by § 1.52(e)(5). The presentation of the “Sequence Listing” and other materials on compact disc under § 1.821(c) does not substitute for the Computer Readable Form that must be submitted on disk, compact disc, or tape in accordance with § 1.824.
(b) The “Sequence Listing” shall, except as otherwise indicated, include the actual nucleotide and/or amino acid sequence, the numeric identifiers and their accompanying information as shown in the following table. The numeric identifier shall be used only in the “Sequence Listing.” The order and presentation of the items of information in the “Sequence Listing” shall conform to the arrangement given below. Each item of information shall begin on a new line and shall begin with the numeric identifier enclosed in angle brackets as shown. The submission of those items of information designated with an “M” is mandatory. The submission of those items of information designated with an “O” is optional. Numeric identifiers <110> through <170> shall only be set forth at the beginning of the “Sequence Listing.” The following table illustrates the numeric identifiers.
Numeric identifier Definition Comments and format Mandatory (M) or optional (O).
<110> Applicant Preferably max. of 10 names; one name per line; preferable format: Surname, Other Names and/or Initials M.
<120> Title of Invention M.
<130> File Reference Personal file reference M when filed prior to assignment of appl. number.
<140> Current Application Number Specify as: US 07/999,999 or PCT/US96/99999 M, if available.
<141> Current Filing Date Specify as: yyyy-mm-dd M, if available.
<150> Prior Application Number Specify as: US 07/999,999 or PCT/US96/99999 M, if applicable include priority documents under 35 USC 119 and 120.
<151> Prior Application Filing Date Specify as: yyyy-mm-dd M, if applicable.
<160> Number of SEQ ID NOs Count includes total number of SEQ ID NOs M.
<170> Software Name of software used to create the Sequence Listing O.
<210> SEQ ID NO:#: Response shall be an integer representing the SEQ ID NO shown M.
<211> Length Respond with an integer expressing the number of bases or amino acid residues M.
<212> Type Whether presented sequence molecule is DNA, RNA, or PRT (protein). If a nucleotide sequence contains both DNA and RNA fragments, the type shall be “DNA.” In addition, the combined DNA/RNA molecule shall be further described in the <220> to <223> feature section M.
<213> Organism Scientific name, i.e., Genus/ species, Unknown or Artificial Sequence. In addition, the “Unknown” or “Artificial Sequence” organisms shall be further described in the <220> to <223> feature section M
<220> Feature Leave blank after <220>. <221-223> provide for a description of points of biological significance in the sequence. M, under the following conditions: if “n,” “Xaa,” or a modified or unusual L-amino acid or modified base was used in a sequence; if ORGANISM is “Artificial Sequence” or “Unknown”; if molecule is combined DNA/RNA”
<221> Name/Key Provide appropriate identifier for feature, preferably from WIPO Standard ST.25 (1998), Appendix 2, Tables 5 and 6 M, under the following conditions: if “n,” “Xaa,” or a modified or unusual L-amino acid or modified base was used in a sequence.
<222> Location Specify location within sequence; where appropriate state number of first and last bases/amino acids in feature M, under the following conditions: if “n,” “Xaa,” or a modified or unusual L-amino acid or modified base was used in a sequence.
<223> Other Information Other relevant information; four lines maximum M, under the following conditions: if “n,” “Xaa,” or a modified or unusual L-amino acid or modified base was used in a sequence; if ORGANISM is “Artificial Sequence” or “Unknown”; if molecule is combined DNA/RNA.
<300> Publication Information Leave blank after <300> O.
<301> Authors Preferably max of ten named authors of publication; specify one name per line; preferable format: Surname, Other Names and/or Initials O.
<302> Title O.
<303> Journal O.
<304> Volume O.
<305> Issue O.
<306> Pages O.
<307> Date Journal date on which data published; specify as yyyy-mm-dd, MMM-yyyy or Season-yyyy O.
<308> Database Accession Number Accession number assigned by database including database name O.
<309> Database Entry Date Date of entry in database; specify as yyyy-mm-dd or MMM-yyyy O.
<310> Patent Document Number Document number; for patent-type citations only. Specify as, for example, US 07/999,999 O.
<311> Patent Filing Date Document filing date, for patent-type citations only; specify as yyyy-mm-dd O.
<312> Publication Date Document publication date, for patent-type citations only; specify as yyyy-mm-dd O.
<313> Relevant Residues FROM (position) TO (position) O.
<400> Sequence SEQ ID NO should follow the numeric identifier and should appear on the line preceding the actual sequence M.
[63 FR 29636, June 1, 1998, as amended at 65 FR 54681, Sept. 8, 2000; 68 FR 38630, June 30, 2003]

Title 37 published on 2013-07-01

The following are only the Rules published in the Federal Register after the published date of Title 37.

For a complete list of all Rules, Proposed Rules, and Notices view the Rulemaking tab.

  • 2014-05-15; vol. 79 # 94 - Thursday, May 15, 2014
    1. 79 FR 27755 - Revisions To Implement the Patent Term Adjustment Provisions of the Leahy-Smith America Invents Act Technical Corrections Act
      GPO FDSys XML | Text
      DEPARTMENT OF COMMERCE, United States Patent and Trademark Office
      Final rule.
      Effective Date: This final rule is effective on May 15, 2014. The interim rule, published April 1, 2013, at 78 FR 19416, was effective on April 1, 2013. Applicability Date: The amendments to 37 CFR 1.702, 1.703, and 1.705 apply to any patent granted on or after January 14, 2013. The amendment to 37 CFR 1.704 applies to any application in which a notice of allowance was mailed on or after April 1, 2013. The optional procedure for requesting a patent term adjustment recalculation applies only to patents issued between January 14, 2013, and May 20, 2014, that resulted directly from international applications, and the request must be filed no later than July 31, 2014.
      37 CFR Part 1

This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.

This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].

It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.


United States Code
U.S. Code: Title 35 - PATENTS

Title 37 published on 2013-07-01

The following are ALL rules, proposed rules, and notices (chronologically) published in the Federal Register relating to 37 CFR 1 after this date.

  • 2014-07-11; vol. 79 # 133 - Friday, July 11, 2014
    1. 79 FR 40035 - Changes To Facilitate Applicant's Authorization of Access to Unpublished U.S. Patent Applications by Foreign Intellectual Property Offices
      GPO FDSys XML | Text
      DEPARTMENT OF COMMERCE, Patent and Trademark Office
      Notice of proposed rulemaking.
      Written comments must be received on or before September 9, 2014.
      37 CFR Part 1